• Cultivate Holdings in its sale to Cresco Labs (CSE:CL) (OTCQX:CRLBF), for upfront consideration equal to $90 million plus an earnout of up to $68 million.
• The Valens Company Inc. (TSX: VLNS) (NASDAQ: VLNS) (NYSE: VLNS), a leading manufacturer of cannabis products, in:
  • its underwritten “bought deal” offering of units resulting in gross proceeds to the company of approximately CDN$32.3 million, including the exercise of the underwriters’ over-allotment option
  • gaining approval for an application to list its common shares on the Nasdaq Capital Market
  • its acquisition of Green Roads worth up to $60 million.
• Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), a multi-state cannabis operator, in a wide variety of matters, including:
  
  • closing its previously announced private placement of 8% Senior Secured Notes due 2026 for aggregate gross proceeds of US$350 million
  • an underwritten public offering worth approximately US$228 million of subordinate voting shares
  • in its C$115.5 million offering of subordinate voting share
  • completion of a Registration Statement on Form S-1 in U.S, and subsequent filings
  • in sale-leaseback transaction with Innovative Industrial Properties, Inc.
  • assisting in drafting the second-highest-scoring Application out of 69 competitive applications in the State of Georgia, receiving a Notice of Intent to Award one of only two Class 1 Production Licenses
  • asset purchases of a Final Marijuana Retailer License in Worcester and a Provisional Marijuana Retailer License in Framingham, and related entitlements. The transactions include cash and stock consideration.
• Columbia Care Inc. (OTCMKTS: CCHWF) in a number of matters, including:
  • its ultimate sale to Cresco Labs for $2 billion, in what is likely the largest transaction in cannabis history to date
  • its acquisition of Green Leaf Medical, LLC, a fully-integrated cannabis multi-state operator based in the mid-Atlantic region, for approximately $240 million with the potential for additional performance-based milestone payments
  • its $42.5 million acquisition of the Van de Wetering Greenhouses
  • its $69 million acquisition of Project Cannabis, a leading California cannabis cultivator, wholesaler and retailer
  • its $140 million acquisition of The Green Solution, a Colorado-based vertically integrated cannabis company
  • in national and state-level intellectual property, patent and trademark filings and related matters
  • its acquisition of vertically integrated cannabis company Medicine Man Denver for $42 million plus additional potential performance-based milestone payments.
• New England Treatment Access, LLC (NETA), a leading Massachusetts-based cannabis company, in its sale to Surterra Wellness.
• Ethos Cannabis in $18 million acquisition of 4Front Venture Corp’s assets in Pennsylvania and Maryland, including five operating dispensaries.
• Ascend Wellness Holdings (OTCMKTS: AAWH) in a number of matters, including:
  
  • its majority investment in MedMed New York
  • its acquisition of Greenleaf Compassion Center, a vertically integrated Cannabis company that holds one of the original six Alternative Treatment Center licenses in New Jersey.
• General Counsel to the New Jersey Cannabis Trade Association, (NJCTA), the trade association for the licensed Alternative Treatment Centers, and several of its members.
• Project managed, advised and drafted applications for multiple clients with winning Ohio RFA-2 Provisional Dispensary Awards under Board of Pharmacy Request for Application for 73 new dispensary licenses, and counseled on related corporate structuring.
• Drafted narratives, project managed and compiled all ownership and financial source documentary information for more than 20 conditional cultivator, manufacturer, and dispensary license award winners and numerous annual applicants in New Jersey Cannabis Regulatory Commission process, and counseled on related corporate structuring.
• Assisted 100% minority-owned MSO client with drafting, project management and disclosures for successfully submitted Pigford Florida MMTC license application and Washington D.C. Medical Cultivator license applications, and counseled on related corporate structuring.
• Drafted and devised corporate structure for three social equity cultivator applicants in Connecticut, and project managed applications.
• Drafted application in New Jersey competitive RFP for Vertically Integrated ATCs with client NETA NJ that scored highest out of applications from more than 146 applicants.
• Drafted, project managed and submitted more than 20 competitive RFP applications for numerous clients in Georgia, Virginia, Illinois, Missouri, New Jersey, and Utah, including multiple winning applications.
• Advising foreign company on NASDAQ listing.
• Provide several clients with regulatory compliance advice regarding the production and distribution of industrial hemp and CBD products, including FDA matters.
• Represented private company in acquisition of controlling interest in Florida MMTC.
• An investment fund in all phases of $23 million investment and acquisition of Massachusetts cultivation, retail operations and real estate.
• Assist clients in drafting applications to Massachusetts Cannabis Control Commission for state marijuana establishment licenses, and successfully secure critical zoning approvals and local approvals.
• Successfully represented clients in securing positive resolution of compliance issues and enforcement orders with Massachusetts Cannabis Control Commission.
• Structured Holding Company for MSO’s subsidiaries in five states and $70mm Capital Raise
• Structured cannabis focused venture fund and parallel fund for direct investments.
• Advise several qualified social equity applicants on founder matters, corporate structuring, financing, and regulatory compliance.
• Represented medical marijuana patients in successful challenge to the Governor’s temporary ban on the sale of cannabis vaporizer products in Massachusetts, securing a preliminary injunction against the ban and defending the validity of the ruling on appeal.
• Currently represent multiple different cannabis companies with regard to union organizing efforts spurred by the labor movement’s desire to organize the industry, particularly in Massachusetts, Illinois and California.
• Negotiated and structured complex joint venture for applicant of dispensary, cultivation and manufacturing licenses, including a debt facility of up to $5 million, and several other production facility joint ventures.
• Negotiated Wholesale, Branding, White-Labeling, Master Services, Licensing, and other commercial agreements on behalf of clients in multiple jurisdictions.
• Large real-estate investor in multiple cannabis-related acquisitions.
• Dozens of clients in multiple states on a variety of formation, structuring, and founder matters.
• Multiple operators at various stages of development and investors in private placements of debt and equity securities.
• Serve as U.S. counsel to national operator with licenses in 13 U.S. states in business combination with NEO-Exchange-traded company.
• National operator in acquisition of chain of Michigan dispensaries.
• CSE-traded MSO in strategic acquisitions in multiple states and national real estate matters.
• Represent CSE-traded company on $60 million acquisition of cannabis company; and serve as special tax and regulatory counsel.
• Counsel emerging ancillary technology and services companies on variety of business and regulatory matters.
• Advised dispensary owner in arbitration with investor regarding terms of the investor’s exit, and related refinancing.